Clinical trial
Observational Prospective Multicentered Study Evaluating Initial Clinical Presentation of Inflammatory Optic Neuritis (ON) Associated or Not With Autoantibodies Anti- Myelin-oligodendrocyte-glycoprotein (MOG-Ab)
NCT03345537 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Prospective Multicentered Study Evaluating Initial Clinical Presentation of Inflammatory Optic Neuritis (ON) Associated or Not With Autoantibodies Anti- Myelin-oligodendrocyte-glycoprotein (MOG-Ab)
- Lead sponsor
- Nantes University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 12, 2018
- Completion date
- March 31, 2022
- Enrollment
- 103 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.